Cardinal Partners is a Princeton, New Jersey–based early-stage venture capital firm that specializes in investments in healthcare technology, life sciences, and related tech-enabled services across the United States. The firm typically participates as a lead or first institutional investor in seed and growth rounds and works closely with entrepreneurs to develop companies with disruptive healthcare and scientific innovations. Founded in 1996, Cardinal has invested in over 100 growth companies and has been involved in multiple successful public offerings and acquisitions. Its portfolio includes companies in biopharmaceuticals, digital health, medical devices and software that support clinical and administrative healthcare functions. The firm’s limited partners include institutional investors such as endowments, foundations, pension funds and insurance companies. cardinalpartners.com reflects its sustained focus on transforming health and healthcare through early-stage investing.